How can affect the mebeverine duspatalin to the pregnant women?
Mebeverine, commonly marketed as Duspatalin, is an antispasmodic medication used to treat irritable bowel syndrome and other gastrointestinal disorders. Its safety during pregnancy has not been extensively studied, and while animal studies have not shown teratogenic effects, the lack of human data warrants caution. Pregnant women should consult their healthcare provider before using mebeverine to weigh potential benefits against any risks. Always prioritize treatments that have established safety profiles during pregnancy.